WuXi AppTec (2359 HK)

622

Analysis

Health Care • China

WuXi AppTec is a global contract research, development, and manufacturing organization (CRDMO) for the pharmaceutical and life sciences industries. It provides integrated, end-to-end services including chemistry drug CRDMO, biology discovery, preclinical testing, and clinical research services for various therapeutic modalities. The company was founded in 2000 and is headquartered in Shanghai, China.

Refresh

bullish•WuXi AppTec

•05 Aug 2026 02:49

Primer: WuXi AppTec (603259 CH) - Aug 2026

WuXi AppTec is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), providing an integrated, end-to-end...

αSK Primers

98 Views

bullish•WuXi AppTec

•05 Aug 2026 02:47

Primer: WuXi AppTec (2359 HK) - Aug 2026

WuXi AppTec is a dominant global Contract Research, Development, and Manufacturing Organization (CRDMO), offering an integrated, end-to-end...

αSK Primers

105 Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00